Future-proofing Cybersecurity in Drug Discovery
The pharmaceutical and biotech sectors suffer more data security breaches than any other industry, with 53% resulting from malicious activity. To protect against potential ...
News
“The awarding of the 2013 Nobel prize in chemistry to three giants of computational methodology has highlighted the importance of molecular modeling in today’s chemical and pharmaceutical industries. Too long regarded as of secondary use, the prize will hopefully promote the technology to its rightful level. Cresset focusses on bridging the gap between theory and bench, bringing innovation from these Nobel winners and others to drug makers and chemists in a transparent and practical way.”
Dr. Andy Vinter, Founder and Chairman, Cresset